Human Cav1.2/CACNA1C Blocking Peptide (#BLP-CC022) is the original antigen used for immunization during Anti-Human CaV1.2 (CACNA1C) Antibody (#ACC-022) generation. The blocking peptide binds and ‘blocks’ Anti-Human Cav1.2/CACNA1C primary antibody, this makes it a good negative reagent control to help confirm antibody specificity in western blot and immunohistochemistry applications. This control is also often called a pre-adsorption control.
- Western blot analysis of rat heart membranes:1. Anti-Human-CaV1.2 (CACNA1C) Antibody (#ACC-022), (1:200).
2. Anti-Human-CaV1.2 (CACNA1C) Antibody, preincubated with Human Cav1.2/CACNA1C Blocking Peptide (#BLP-CC022).
- VNENTRMYIPEENHQ(C), corresponding to amino acid residues 2-15 of human CaV1.2 (exon 1B) (Accession Q13936).